Hepatitis-B Vaccine
Hepatitis B is mainly a disease of injected-drug addicts and sex trade workers; the hepatitis B virus is acquired by contact with infected body fluids. The disease is uncommon and very many cases, especially the young, have no symptoms, recover completely and then are immune for the rest of their lives. The life-threatening complications of hepatitis B infection – cirrhosis and liver cancer – take ten to thirty years to develop and, according to statistics, cause death in fewer than one quarter of one percent (<0.25%) of those infected. But even that rate may be an overestimate since deaths of hepatitis B infected drug addicts and alcoholics may actually be due to their liver-intoxicating habits and not the virus.
Babies are not engaged in these high risk activities that put them at risk of acquiring the disease. If they have acquired the virus from their mothers, they are given an injection of hepatitis B antibodies and vaccinated in the hope that that will prevent them from contracting the disease. But what’s the excuse for vaccinating the uninfected majority of the infant population? Perhaps the reason has something to do with the fact that infants are much easier to corral than street people; and their parents are more apt than residents of the streets to accept vaccination after hearing fear mongering lectures from Public Health.
It’s unclear whether or not hepatitis B vaccines used for Canadian infant and child vaccination programs still contain mercury. The surest way to know if your child is being offered a vaccine containing mercury is to ask to see the container. A 0.5 ml vial for infants or a 1.0 ml vial for older children is a single dose container which is thrown away after the syringe is withdrawn. If the container is larger, it contains enough vaccine for several doses and must contain a preservative. The preservative in hepatitis B vaccine is Thimerosal, a compound which is approximately 50% mercury.
1. Hepatitis B Disease and its Vaccine
2. Articles on Hepatitis B Vaccine by Marc Girard, MSc MD
3. The Saga of Pediatric Hepatitis B Vaccination by F Edward Yazbak, MD FAAP ( a discussion of expert testimonial, information exchanged at meetings between vaccine producers and regulators, and adverse event reports)
4. Bonnie Dunbar PhD, Professor at Baylor College of Medicine Speaks(an excerpt from a speech to the Second International Public Conference on Vaccination, Arlington, Virginia, Sept 2000)
5. Research Proposal (Bonnie Dunbar, PhD writes about her research proposal to study autoimmune reactions to hepatitis B vaccine)
6. Hepatitis B Vaccine: Helping or Hurting Public Health?(the Association of American Physicians and Surgeons 1999 testimony in the US House of Representatives)
7. National Vaccine Information Center articles on hepatitis B vaccine
8. Experts Question the Value of Hepatitis B Vaccine by Carolyn De Marco, MD
9. Canadian Medical Association Says “No” to Mandatory Vaccination and Screening for MDs
10. Nightingale Research Foundation Press Release, 1994 (questions introduction of hepatitis B vaccination programs in Ontario and Quebec)
11. Hepatitis B Vaccination and Chronic Fatigue Syndrome (testimony by Byron Hyde, MD before the Quebec College of Physicians Medical Board Tribunal)
12. Adverse Reaction Testimonials (excerpts from patients’ letters)
14. Hepatitis B Vaccine Linked to Diabetes (evidence from Bart Classen, MD MBA)
15. Medical Journal Articles Linking Hepatitis B Vaccine to Pathologies